Understanding the Market | H&H International Holdings fell over 5%, with net profit in the first half down nearly 77% year-on-year, and an interim dividend of HKD 0.19 declared
H&H International Holdings fell over 5%, as of the time of writing, down 4.82%, reported at HKD 13.23, with a transaction volume of HKD 66.055 million. In terms of news, H&H International Holdings released its interim results for the six months ending June 30, 2025, with the group achieving revenue of RMB 7.019 billion, an increase of 4.89% year-on-year; profit attributable to the parent company was HKD 71.017 million, a decrease of 76.78% year-on-year; basic earnings per share were HKD 0.11. It proposed an interim dividend of HKD 0.19 per ordinary share, compared to HKD 0.30 in the same period last year. The announcement stated that the increase in revenue was mainly due to growth in all business segments (i.e., adult nutrition and care products, infant nutrition and care products, and pet nutrition and care products). For the six months ending June 30, 2025, revenue from high-margin nutritional supplements across all three business segments grew by 4.6% year-on-year on a comparable basis, accounting for 65.6% of the group's total revenue
According to Zhitong Finance APP, H&H International Holdings (01112) fell over 5%, and as of the time of writing, it was down 4.82%, priced at HKD 13.23, with a transaction volume of HKD 66.055 million.
In terms of news, H&H International Holdings announced its interim results for the six months ending June 30, 2025, with the group achieving revenue of RMB 7.019 billion, an increase of 4.89% year-on-year; the profit attributable to the parent company was RMB 71.017 million, a decrease of 76.78% year-on-year; basic earnings per share were RMB 0.11. A proposed interim dividend of HKD 0.19 per ordinary share will be distributed, compared to HKD 0.30 in the same period last year.
The announcement stated that the increase in revenue was mainly due to growth in all business segments (i.e., adult nutrition and care products, infant nutrition and care products, and pet nutrition and care products). For the six months ending June 30, 2025, the revenue from high-margin nutritional supplements across all three business segments grew by 4.6% year-on-year based on comparable benchmarks, accounting for 65.6% of the group's total revenue
